1.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: J1070, RC2CA148346-01, NA_00032826, NCT01296763
|
|
2.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: GECP10-03, 2010-024178-21, NCT01513174
|
|
3.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: ISS22810034, NCT01650376
|
|
4.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 11-470, NCT01583543
|
|
5.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: ICR-CTSU/2011/10030, 2011-000601-49, CRUK/C12540/A12354, ISRCTN15124653, ISS22810018, NCT01682772
|
|
6.
|
Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: D0810C00024, NCT00777582
|
|
7.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: 110022, 11-C-0022, NCT01237067
|
|
8.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Diagnostic, Treatment Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: CDR0000702605, CRUK-CR0901-11, EUDRACT-2010-018615-15, CR0901-11, NCT01390571
|
|
9.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: 080092, 08-C-0092, NCT01445418
|
|
10.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Other Protocol IDs: 10_DOG03_194, NCT01460888
|
|
11.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: NL35195.031.11, N11ORL, NCT01562210
|
|
12.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Other Protocol IDs: 12-159, NCT01623349
|
|
13.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: ISS22810031, NCT01644266
|